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ABstract  When  mouse  B lymphocytes  are  incubated  with  antibodies against  their surface 
immunoglobulin  (Ig), patching and capping occur in a process that involves the action of the 
actomyosin  cytoskeleton  and  the  mobilization  of  cell  calcium.  Calmodulin  (CAM)  plays  a 
central  role  in  the Ca ++  regulation  of  many cellular  structures  and  processes, including  the 
cytoskeleton  and  membrane-bound  enzymes,  and  therefore  was  investigated for  its role  in 
capping. CaM was isolated from  mouse  lymphocytes by affinity chromatography on Fluphen- 
azine-Sepharose.  Lymphocyte  CaM co-migrates  with calf  brain  CaM on  SDS polyacrylamide 
gels, where its rt is Ca++-dependent.  It stimulates the activity of the CaM-dependent  cyclic 
AMP  phosphodiesterase  (PDE) of  bovine  heart.  Several phenothiazine  and  thioxanthene 
compounds  as well  as the drugs W7,  WS,  and  R24571 inhibit CaM  in in vitro enzyme assays 
with ID~o's of from  1 /~M to >1  mM. These were tested  for their effects on capping of Ig and 
were found  to inhibit capping in dose-dependent  fashions with ID~o'S that corresponded  to 
their anti-CaM  potencies. The  drugs also  disrupted  preformed  caps and  were all  reversible. 
CaM  was  localized  in  lymphocytes  by  staining  with  a  highly  fluorescent  trifluoperazine 
derivative (TFP*) produced  by photo-oxidation. TFP* staining was diffuse  in  untreated  lym- 
phocytes  but  stained  under  caps  and  in  uropods  in  cells  capped  with  anti-lg  antibodies. 
Staining of cells with antibodies against calf brain and rat testis calmodulin gave similar staining 
patterns.  Staining of patched cells with either antibodies or TFP* showed patched distributions 
of  CaM,  but  submembranous  CaM  "patches"  did  not  map  one-on-one  with  respect  to  Ig 
patches. These observations suggest that calmodulin  participates in the latter stages of ligand- 
induced  Ig redistribution probably by regulating the interaction of the cytoskeleton with the 
membrane. 
The capping of surface immunoglobulin on B lymphocytes is 
a dramatic example of surface receptor redistribution mediated 
by components of the underlying cytoskeleton (5, 21,  32,  53, 
57).  The arrangement and regulation of the cell's actomyosin- 
based  motility  apparatus  and  the  means  by  which  surface 
receptors  are  connected  to  this  machinery  through  the  lipid 
bilayer are two of the central issues in understanding  patching 
and capping. Cross-linking of receptors by multivalent ligands 
is  required  to  initiate  the  energy-independent  patching  of 
receptors that must occur before the energy-dependent,  cyto- 
skeleton-mediated capping process gathers the patched recep- 
tors to one  pole of the  celi (40,  57,  58,  59).  It is during  the 
patching phase of receptor movement that initial connections 
to the cytoskeleton are made (3,  5,  14,  18, 20,  71).  The cell's 
motility machinery then coordinates the movement of receptor 
aggregates. These two physiologically and structurally distinct 
steps may be regulated in similar or dissimilar ways. 
One  known  regulatory  species  whose  local  distribution  is 
altered  during cross-linking and  patching is the calcium ion. 
Cross-linking of surface immunoglobulin (Ig) by anti-Ig anti- 
bodies induces movement of protein-associated Ca ++ to lipid 
regions of the membrane, as reported by the fluorescent probe 
chlorotetracycline (32).  45Ca+÷ efflux from intact lymphocytes 
occurs subsequent to cross-linking (7).  Studies of the effects of 
free-fatty acids on membrane structure  ana capping have led 
to the description of membrane domains and implicate changes 
in local Ca ++ distribution  as occuring concomitantly with the 
cross-linking of immunoglobulin receptors (32,  33). 
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as well as in their patching. In the presence of external calcium, 
the calcium ionophore A23187 is a potent inhibitor of capping 
(but not patching) and will even disperse preformed caps in an 
energy dependent  process  (6,  53).  Cis-unsaturated  free  fatty 
acids will inhibit capping (but not patching) and can induce 
changes in the arrangement of the cytoskeleton--these effects 
are antagonized by high concentrations of extracellular calcium 
(29, 32).  A variety of tertiary amine anesthetics and tranquil- 
izers  act as  capping inhibitors  and  in  some cells  have  been 
reported to dissociate microfilaments from the cell membrane 
(2, 6, 42, 48, 51, 72). Their anti-capping affects are also antag- 
onized by high extracellular calcium. These observations indi- 
cate a  role for calcium in maintaining  the connection of the 
cytoskeleton to the membrane.  The regulation by calcium of 
microtubule  polymerization,  actomyosin-based  contraction 
and cell motility is well documented (11, 23, 24, 26, 28, 41, 43, 
62) and must also be considered in the context of capping. 
The common theme of calcium control unites these obser- 
vations and recent studies suggest that the protein calmodulin 
may provide the key to understanding the molecular basis of 
this calcium control. Calmodulin  (CAM)  is a  ubiquitous cal- 
cium-binding protein that has been found to regulate a variety 
of cellular processes in eukaryotes; many of these processes are 
directly relevant to capping (10,  11). Calmodulin regulates the 
Ca++/Mg  ÷+ ATPases of cell membranes and thereby the inter- 
nal ionic states of cells (34, 44). It regulates the polymerization 
of microtubules in vitro and is associated with microtubules in 
vivo (13, 41, 68).  Actomyosin in smooth and skeletal muscles 
is  regulated  via the  calmodulin  dependence  of myosin light 
chain kinase  (23,  24,  28, 62).  The shapes and ligand binding 
properties of platelets are altered by calmodulin inhibitors (31). 
Immunocytochemical localization of calmodulin shows it to be 
associated with stress fibers or microfilament bundles and the 
mitotic  spindles  of fibroblasts  as  well  as  with  postsynaptic 
densities  of nerve  membranes  (13,  25,  63,  68,  70).  Finally, 
several of the drugs that  are known to inhibit  capping have 
been shown to be potent specific inhibitors of calmodulin in in 
vitro enzyme systems (22, 34, 36, 56, 60, 61, 64, 66, 67). These 
observations prompted us to investigate directly whether cal- 
modulin plays a role in lymphocyte capping. 
In  this  paper  we  identify  and  characterize  a  calmodulin 
protein  from  murine  splenic  lymphocytes.  The  preferential 
distribution  of  calmodulin  under  immunoglobulin  caps  is 
mapped  with  anti-calmodulin  antibodies  and  a  fluorescent 
calmodulin-binding  drug.  The  dose-dependent  inhibition  of 
capping by a variety of calmodulin-specific inhibitors is then 
demonstrated.  Finally,  these  observations  are  all  interpreted 
along with  earlier  observations  in  terms  of how calmodulin 
may regulate  capping of surface  immunoglobulin  and  other 
surface receptors. 
MATERIALS  AND  METHODS 
Lymphocyte Isolation and Capping Protocol 
Spleens were dissected from B6AF l/J mice (Jackson Laboratories, Bar Har- 
bor, ME) into phosphate buffered saline (PBS) and teased to release ceils from 
the capsule. Lympbocytes were washed and suspended in cold PBS following 
hypotonic lysis of contaminating erythrocytes. 3  x  l0  s lymphocytes were sus- 
pended in 250 ,td of buffer and incubated with 12-15 t-d of fluorescently tagged 
antibodies (fluorescein isothiocyanate labeled goat anti-mouse Immunoglobulin 
G heavy and light chains IFITC-GAMIg], Bionetics Laboratory Products, Litton 
Bionetics,  Inc.,  Kensington, MD,  or rhodamine isothiocyanate-labeled rabbit 
anti-mouse immunoglobulin G  heavy and light chains [RITC-RAMIg], Cappel 
Laboratories Inc., Cochranville, PA). The cells were washed with 15 ml of PBS 
and resuspended in a  volume of 0.5 ml. For patching, cells were incubated for 
20-30 min at 23°C in PBS containing 10 mM NaN:~. For capping, the lymphocytes 
were warmed to 23°C for 30 rain. Reactions were stopped by fixing the ceils in 
excess  3.7%  formaldehyde  1% methanol in  PBS.  For drug inhibition  studies 
capping and patching  were performed as above, except that all solutions contained 
the drug and the cells were incubated with the drug for 20 rain on ice before 
addition of the antisera. For cap dispersal tests, the lymphocytes were capped in 
PBS as above. Then 0.5 ml of 2 x  concentration of drug was added and the ceils 
were incubated for an additional 15 rain at 23 °C followed by fixation. Reversi- 
bility of the drugs was measured by incubating the lymphocytes in drug solutions 
at their 50% and minimum 100% effective doses (for capping inhibition) for 20 
rain at 0°C. The cells were then washed four times in PBS for 5 min at 0°C and 
warmed for 15 rain to recover. They were then processed for capping as above. 
Preparation  of Calf Brain Calmodulin for 
Antibody Elicitation and as a 
Biochemical Standard 
Purified calmodulin was prepared from calf brain by the method of Watterson 
et al. (65) or by a modification of the Flupbenazine-Sepharose affinity chroma- 
tography method of Charbonneau and Cormier (9) with similar results and yields 
of 23-27 nag calmodulin per 6  calf brains (~ 1 kg wet weight). Fluphenazine- 
Sepharose 4B  was prepared  according to  the  protocol of Charbonneau  and 
Cormier (9). 
Purification of Calmodulin from Lymphocytes 
Lymphocytes from 35  B6AFI/J males were isolated as for capping experi- 
ments. 1.6 x  109 cells were suspended in 16 ml of 50 mM HEPES, 0.15 M NaC1, 
0.1 mM PMSF, pH 7.0 and lysed by nitrogen cavitation (equilibration at 400 psi 
for 5 rain followed by slow exhaust) in a Parr model 4635 cell disruption bomb 
(Parr Instrument Co., Moline, IL). The lysate was cleared by centrifugation for 
30 min at 100,000 g and the supernatant brought to 0.5 M in NaCI and 10 mM 
in  CaCI2. This material was applied  to  a  15 ml  Fluphenazine-Sepharose 4B 
affinity column and calmodulin was  eluted  with  10 mM  EGTA,  pH  7.8  as 
described by Charbonneau and Cormier (9). 
Preparation  of Antisera  and Affinity Purification 
Four New Zealand albino rabbits were inoculated with 0.5 mg of dinitro- 
phenylated calmodulin (DNB-CaM)  in  Freund's complete  adjuvant  (Cappel 
Laboratories Inc.). DNB-CaM was prepared according to Wallace and Cheung 
(63). Rabbits were boosted on day 32 with 0.5 mg of DNB-CaM and on days 44, 
50, and 65 with 0.5 mg of native calmodulin in incomplete adjuvant. Sera were 
collected 7 d  after injections and screened for activity by indirect immunofluo- 
rescent staining of cultured cells and serum from the rabbit that gave the brightest 
staining was further characterized and affinity purified by chromatography on 
calmodulin-Sepharose. Calmodulin-Sepharose was prepared according to Niggli 
et  al.  (44);  10  nag of calmodulin was coupled  to  2.5  ml  of CNBr-activated 
Sepharose 4B. 12 ml of serum 115 (46 mg/ml protein) was incubated with CaM- 
Sepharose as a slurry for 1 h at 4°C in phosphate buffered saline, loaded into a 
10 ml syringe barrel and washed. CaM binding antibodies were eluted with 0.2 
M glyeine pH 2.8 and protein peak fractions were pooled, dialyzed against PBS 
+  0.01% NaN3 and stored frozen in aliquots at 0.13 mg/ml. 
Staining of Lymphocytes  with Anti- 
Calmodulin Antibodies 
Anti-CaM antibodies were used to stain lymphocytes in various states of Ig 
receptor distribution by indirect immunofluorescence. Unchallenged, patched, 
and capped lymphocytes (patched and capped with FITC-GAMIg) were fixed 
with 3.7% formaldehyde plus  1% methanol in PBS and allowed to settle onto 
polyethyleneimine coated eoverslips at 1 g. The cells were incubated with 0.1 M 
L-lysine pH 7.5 to block unreacted aldehydes and permeabilized by immersion 
for 3-5 rain m acetone cooled on dry ice. The cells were rehydrated in PBS and 
used for staining. Coverslips were inverted over I% BSA +  I% normal goat serum 
in  PBS  for  1  h  to  block  nonspecific absorption of protein  to  the  cells  and 
coverslips and stained with 25/d of anti-CaM antibodies at 1:10 dilution in PBS 
plus  1% BSA and 1% goat serum overnight at 4°C. The coverslips were rinsed 
three  times  for 30 rain in  PBS  then  incubated with  absorbed RITC-GARIg 
antibodies at 1:100 dilution in PBS plus 1% BSA and 1% goat serum for 2 h  at 
23°C, rinsed several times with PBS and mounted over 50% glycerol in PBS plus 
0.01% NAN3. Absorption of RITC-GARIg was done by incubating the antibodies 
overnight at 4°C with an acetone precipitate of mouse splenic lymphocytes that 
had been fixed with 2% glutaraldehyde for 30 min and blocked with 0.1  M  L- 
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was spun out for 3  min in a  Beckman microcentrifuge (Beckman Instruments, 
Inc.. Fullenon, CA) and the soluble RITC-GARIg used as above to label the 
bound  rabbit  anti-CaM  antibodies.  Control  staining consisted of the  second 
serum alone,  which gave very low background stain, or of primary and then 
secondary antibody where primary staining was conducted in the presence of 
soluble CaM: the latter gave significantly reduced intensity. Identical procedures 
were used to stain cells with sheep anti-rat testis calmodulin (CAABCO, Inc., 
Houston, TX)  using FITC-Rabbit anti-sheep antibodies (Cappel  Laboratories, 
Inc.) in  1% rabbit serum plus 1% BSA as secondary serum. 
Indirect immunofluorescence of cultured cells grown on glass coverslips was 
performed according to Fujiwara and Pollard (19) using rabbit antibodies against 
calmodulin, as well as fish muscle actin and chicken gizzard myosin antibodies 
generously supplied by Dr. Keigi Fujiwara. In all cases the cells were fixed in 
3.7% formaldehyde, acetone-permeabilized and stained with antibodies as above 
in the presence of 1% BSA and  I% goat serum. Goat anti-rabbit Ig antibodies 
were  preabsorbed with glutaraldehyde-fixed acetone precipitates of the  target 
ceils. 
Staining of Cells with Photo- 
oxidized Trifluoperazine 
Live cells or cells preserved by a  variety of methods were used for staining 
with trifluoperazine (TFP)  and nearly identical results were obtained with all 
methods of preservation. Cells fixed for 10 min in 3.7%  formaldehyde in  PBS 
gave the best staining. Cold acetone permeabilization alone or in combination 
with  formaldehyde fixation  and antibody staining produced similar staining 
patterns but were somewhat reduced in intensity. Live ceils were indistinguishable 
from formaldehyde-fixed cells when stained for  1 or 2  min and immediately 
observed, but TFP can induce morphological changes in ceils after only a  few 
minutes. The  most convenient staining method was to  mount coverslips with 
attached ceils on a slide containing a drop of 3 ×  10  -6 M  to 1 ×  10  4 M TFP in 
PBS plus 1 mM CaCI~.  The coverslips are then rinsed in PBS before mounting. 
Rinsing can sometimes be eliminated as background fluorescence is quite low 
and no obvious differences in  staining pattern are obtained. The slide is then 
UV-irradiated  directly  for  l0  min  using a  mineral  light or  mounted  on  the 
microscope,  and  selected  fields  are  irradiated  individually  for  10-30  s  with 
unfiltered UV or the  filtered light from the  Leitz filter combination #513410 
used for observation on a Leitz Ortholux I1 microscope equipped for epifluores- 
cence. Yellowish fluorescence appears almost immediately and intensity stabilizes 
after a minute or less depending upon the drug concentration used. When using 
double  fluorescent  staining with  fluorescein-tagged antibodies  it  was a  good 
practice to observe and photograph the fluorescein (as it bleaches) before irra- 
diating for photo-oxidized TFP* observation. 
Phosphodiesterase  Measurements 
Assays of 3':5'-cyclic AMP phosphodiesterase from bovine heart were by a 
modification of the procedure of Butcher and Sutherland (9).  Briefly, 60 #1 of 
sample (containing CaM) was added to 420 #1 of 0.1  M glycine, 2.86 mM CaCI._,. 
1.43  mM  MgSO4,  pH  7.5.  60  #I  of  phosphodiesterase  (0.02-0.04  U,  Sigma 
Chemical Co., St. Louis, MO) in 20 mM imidazole, 0.1  M glycine, pH 75, from 
frozen aliquots was then combined. The reaction was started by adding 60/tl of 
6 mM cyclic AMP in 0.1 M glycine, pH 7.5 (made fresh or stored at -70°C), and 
incubating for 30 min at 37°C. The  first reaction was stopped by boiling and 
flocculant material, if present, was spun out at 2,000 g  for 5  min. 0.1  unit of 
5'nucleotidase (Crotalus atrox, Sigma Chemical Co.) in 100 #1 of 3.3 mM MnClz, 
0.1 M glycine, pH 7.5, was added to initiate the cleavage of phosphate from AMP 
and incubated for 15 min at 37°C. The 5'nucleotidase reaction was stopped with 
200/xl of 0.25 M ZnSO~ pH adjusted to 2.5 with HeSO4 and phosphate measured 
in duplicate 0.3-ml aliquots from the above solution according to Eibl and Lands 
(16). 
Gel Electrophoresis 
SDS  PAGE was processed according to  Laemmli (35).  Samples sometimes 
included 10 mM CaCI~ or 10 mM EGTA for assaying conformational changes in 
CaM. 2 mM EGTA was included in the resolving gel buffer when it was necessary 
to  suppress smearing or heterogeneity of CaM  in  samples in  which calcium 
concentration was not controlled, lsoelectric focusing was according to the first 
dimension protocol of O'Farrel (46) substituting an ampholine mixture of h I pH 
2.5~1:  pH 3.5  10 (LKB  Instruments, Inc., Rockville, MD).  Alkaline urea gels 
were run according to Head and Perry (26) using 3.5 M urea instead of 6 M. 
Coomassie Blue staining for SDS PAGE was according to Fairbanks et al. 
(17) and silver staining was according to Oakley et al. (45). Isoelectric focussing 
(1EF) gels were stained with (a) 50% trichloroacetic acid, 0.1% Coomassie Blue 
and destained in  10% isopropanol, 10% acetic acid or (b) fixed in 50% trichloro- 
acetic acid  followed  by several  washes in  10% ethanol,  1~,  acetic acid and 
processed according to  Oakley et  aL  pH gradients were  measured  by slicing 
frozen IEF gels into half cm sections, incubating the sections for 2 h in  I ml of 
distilled water and measuring the pH of the resulting solutions. 
Sources of Materials 
Trifluoperazine.2  HCI,  trifluoperazine  sulfoxide.2HCl,  chlorpromazine. 
HCI, chlorpromazine sulfoxide. HC1 and prochlorperazine •  2 HCI were gifts from 
Smith,  Kline and French Laboratories, Philadelphia,  PA. Trifluopromazine.2 
HCI and Fluphenazine.2 HCI were obtained from E. R. Squibb & Sons, Inc., 
Princeton, NJ. Thiothixene.HCl was purchased from Pfizer,  Inc.,  New York, 
NY. Chlorprothixene. HCI was purchased from Hoffmann-LaRoche. Nutley. NJ 
and  R24571,  an  analogue of the  antiseptic  Sepazonium,  was obtained  from 
Janssen Pharmaceutica, Beerse, Belgium. Propranolol was purchased from Sigma 
Chemical Co., St. Louis, MO and compounds W7 and W5 were from Rikaken 
Co.. Ltd., Nagoya, Japan. Acrylamide and N,N'-methylene bis-acrylamide were 
purchased from Bio-Rad Laboratories, Richmond, CA and glutaraldehyde was 
obtained  from Alpha  Products, Danvers,  MA.  All other materials were from 
Sigma Chemical Co., or Fisher Scientific Co., Pittsburgh, PA. 
RESULTS 
Purification and Characterization of 
Brain Calmodulin 
Calmodulin (CAM) from calf brain was purified for use as a 
biochemical standard and for eliciting anti-CaM  antibodies in 
rabbit by two standard methods, each of which gave essentially 
the same results. CaM was judged to be pure by SDS  PAGE 
and  alkaline  urea  gels  and  ran  as  a  single  electrophoretic 
species.  The  apparent  molecular  weight  (M.oo)  in  SDS  gels 
varied  with calcium concentration  from M,vo  =  i7,900  +  or 
-  1400  (N  =  4) in the  presence of  10 mM  CaCI,,  to M,po  = 
20,500  +  or -  1100  (N  =  3)  when  the  sample contained  10 
mM EGTA. The protein stimulated 3':5'-cyclic AMP phospho- 
diesterase from bovine  heart in a  calcium-dependent  fashion 
and had an isoelectric point ofpH 3.9 with a minor component 
at pH 4.0 (Fig.  1). Elution of the protein from a Fluphenazine- 
Sepharose affinity column with EGTA  demonstrated the cal- 
cium-dependent binding of CaM to the phenothiazine. 
Purification of Calmodulin from L  ymphocytes 
Calmodulin was  isolated  from  100,000  g  supernatant of 
murine splenic lymphocytes by Fluphenazine-Sepharose affin- 
ity  purification.  CaM-containing  fractions  eluted  from  the 
affinity column beginning  about one bed volume after appli- 
cation  of  EGTA-containing  elution  buffer.  SDS  PAGE  of 
elution fractions showed that CaM in early fractions migrated 
with an apparent molecular weight of 18,000 but, this increased 
to M,pp =  20,200  in later fractions containing  10 mM EGTA 
and these co-migrated with brain CaM  (also applied  with  10 
mM EGTA)  (Fig.  1), transition fractions, CaM  migrated as a 
doublet.  With  silver staining,  proteins  vary  in  staining  color 
from reddish brown to smokey gray and both lymphocyte and 
calf brain CaM stained gray. Occasionally, proteins of molec- 
ular weights 28,000,  44,000,  and 72,000 eluted with CaM  and 
may represent CaM-binding  proteins as their apparent abun- 
dance on gels parallels  that of CaM  for various elution frac- 
tions.  They  may  also  be  phenothiazine-binding  proteins  in 
their own right. We have encountered similar contaminants in 
affinity  purifications  of CaM  from  neutrophils  and  CH1  B- 
lymphoma  cells.  Phosphodiesterase  (PDE)  measurements  on 
elution  fractions  showed  them  to  have  little  or  no  intrinsic 
PDE  activity,  but  they  stimulated  exogenously  added  PDE 
from bovine heart. Peak PDE stimulatory activity and intensity 
N~tsoN  tr  At.  Capping  ofSurtace Immunoglobulin  773 TFPSO and CPZSO, which were indistinguishable from con- 
trols. Dispersal was effective within  15 min at room tempera- 
ture even in the presence of 3-10 mM sodium azide (Fig. 3). 
Calmodulin inhibitors were reversible and ceils recovered well 
from exposure to the drugs following several brief washes and 
a  15-min recovery period at room temperature (Fig. 3). 
FIGURE  1  Properties of lymphocyte calmodulin. Plate at left shows 
the purification of lymphocyte calmodulin by Fluphenazine-Seph- 
arose affinity chromatography as analyzed by SDS PAGE on a 12.5% 
acrylamide gel, silver stained. (A) 100,000 g supernatant of lympho- 
cytes.  (B)  Pooled elution fractions containing lymphocyte calmod- 
ulin.  (C)  Calf brain calmodulin  used as a standard  (2 #g).  Plate at 
right shows isoelectric focussing gels of calf brain calmodulin  (CB) 
stained  with  Coomassie  Blue,  and  lymphocyte  calmodulin  (/_C) 
stained with  silver. Both proteins have isoelectric points of pH 3.9. 
A minor component of the brain protein runs with a pl of pH 3.95. 
Dense staining of the extremities of the silver stained gel is due to 
ampholines. 
of the  18-21,000 mol wt protein band were obtained from the 
same  fractions.  Electrophoresis  of  pooled  CaM  fractions 
showed that the change in molecular weight as a  function of 
calcium corresponded precisely to that of brain CaM. Isoelec- 
tric focusing of the pooled protein gave an isoelectric point of 
pH 3.9 (Fig. 1). From protein determinations and densitometry 
of SDS PAGE bands, we made the crude estimate that CaM 
isolated by affinity chromatography from soluble cell protein 
comprises of the order of 0.1% of soluble cell protein or 50-60 
~g per 109 cells. 
Anti-Capping  Effects of Calmodulin 
Inhibiting Drugs 
Dose-response curves for capping inhibition were obtained 
with the new CaM-inhibiting drugs R24571,  W7, W5, and a 
variety of phenothiazines and  thioxanthenes  (Fig.  2).  These 
include:  trifluoperazine  (TFP),  tritluoperazine  sulfoxide 
(TFPSO),  chlorpromazine  (CPZ),  chlorpromazine  sulfoxide 
(CPZSO),  trifluopromazine (TPZ),  fluphenazine (FPZ), pro- 
chlorperazine (PCP),  chlorprothixene (CPT),  and thiothixene 
(TT). All of the phenothiazines and thioxanthenes except two 
inhibited capping at micromolar concentrations with IDa's of 
2040/tM.  Two analogues, TFPSO and CPZSO, were ineffec- 
tive inhibitors; for these, IDa's were > 1 mM. D, 1-propranolol 
was  a  weak inhibitor with  ID~o =  550  ~M.  R24571  was  the 
most potent inhibitor with IDso =  1/.tM. W7 was 50% effective 
at 20/tM whereas its weaker analogue, W5, had an ID~o of 170 
/~M.  IDa's  for  capping  inhibition  paralleled the  inhibitions 
measured  in  vitro for CaM-stimulated activity, showing that 
the  specificities are  such  as  would  be  expected for  a  CaM- 
dependent process (22, 27, 60, 64, 66, 67). The ability  to disperse 
preformed caps was  obvious for all of the  analogues except 
Controls for General Membrane Perturbation 
Because phenothiazine tranquilizers and tertiary amine an- 
esthetics are  thought  to  be  membrane-active substances,  we 
tested several of the analogues to find out whether their anti- 
capping effects might be due to a general change in membrane 
structure or activity. TFP, CPZ, and their sulfoxide derivatives 
were tested for their ability to perturb the fluorescence polari- 
zation  of the  probe  diphenylhexatriene (DPH)  (31,  48).  10  7 
lymphocytes were  treated with  phenothiazines for 30  min  at 
room temperature, washed three times in PBS, and suspended 
in 2/.tM DPH in PBS for fluorescence depolarization measure- 
ments using an Elscint model MVIA microviscometer. None 
of the four phenothiazines affected the fluorescence depolari- 
zation values for DPH at concentrations from  10  -'5 to  10  -4 M 
(at  which  concentration  total  capping  inhibition  occurs  for 
TFP  and  CPZ).  Thus  the  rotational  diffusion  of  DPH  (a 
measure of fatty acyl chain ordering) was not affected. Woda 
et al. (69) have shown that CPZ at similar concentrations leads 
to  only perfunctory increases in  lateral diffusion of Fab'-la- 
beled surface immunoglobulin and the lipid probe Hedaf (5- 
(N-hexadecanoyl)aminofluorescein). 
Fluorescent Localization of Calmodulin  with 
Photo-oxidized Trifluoperazine 
Trifluoperazine can be photo-oxidized to highly fluorescent 
derivative(s) (TFP*)  that  can  be made  to  bind reversibly or 
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FIGURE  2  Calmodulin inhibitors are inhibitors of lymphocyte cap- 
ping.  Dose-response curves  for capping inhibition  were obtained 
with  the  CaM-inhibiting  drugs  R24571 (A),  W7(41,),  W5(~), the 
phenothiazines trifluoperazine (TFP, 0), Chlorpromazine (CPZ, II), 
and their sulfoxide derivatives (TFP-SO,  0 and  CPZ-SO, I-1). IDso's 
for capping inhibition  paralleled the inhibitory doses measured in 
vitro for CaM-stimulated enzymes. Lymphocytes were incubated for 
20 min on ice with the drugs in PBS. Anti-lg antibodies were added 
and  after  a  further  20-min  incubation  at  0°C  were  washed  and 
warmed to room temperature for 30 rain to cap. The reaction was 
stopped by fixation with  formaldehyde. Error bars show mean and 
standard deviation for two or more determinations on at least 250 
cells. 
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FIGURE  3  Reversibility of drugs and dispersal of preformed caps. The ability to disperse preformed caps was obvious for all of the 
effective capping inhibitors tested  (left panel). Trifluoperazine sulfoxide and chlorpromazine sulfoxide, which are  not effective 
inhibitors, were indistinguishable from controls at up to 100/~M. Dispersal was effective within 15 rain at room temperature even 
in  the presence of 3  to  10 mM sodium azide.  Cells were  capped  for 30  min at  room  temperature  in  PBS followed  by a  15-min 
exposure to the drug tested. 1o measure the reversibility of capping inhibitors, lymphocytes were incubated with drugs for 30 min 
at O°C, washed four times for 30 min with PBS, and warmed to room temperature for 20 min to allow recovery. The cells were then 
processed  for capping as usual.  Right panel shows the degree of capping for lymphocytes processed as above (stippled) and the 
corresponding degree of capping inhibition obtained with the same drug doses (striped). The difference between the two values 
reflects  the  degree of  recovery  from  the  drugs.  TFP  and  CPZ  stand  for  trifluoperazine and  chlorpromazine,  respectively. 
Abbreviations for other phenothiazine and thioxanthene compounds are in the text. 
irreversibly to CaM depending upon the procedure used. This 
property allows visualization of TFP binding sites (CAM) by 
fluorescence. O'Kane et al. (47) showed that one of the TFP 
photo-oxidation products made by UV irradiation of TFP in 
aqueous  solution would  bind  reversibly to  CaM  in  a  Ca +÷- 
dependent fashion. This product stained CaM in nondenatur- 
ing acrylamide gels. The acrosomes of guinea pig sperm per- 
fused with the derivative were also visualized using an image 
intensification system and the staining pattern corresponded to 
the staining with anti-CaM antibodies. Prozialeck et al. (50, 66) 
recently demonstrated that if tritiated CPZ or TFP are irradi- 
ated  in  the  presence  of CaM  or other proteins,  irreversible 
Ca++-dependent binding of the tritiated drugs to CaM occurs, 
but observed no significant binding to other proteins. We have 
combined the irreversibility  and fluorescence properties of  TFP 
to irreversibly stain CaM in lymphocytes and other cells. The 
irreversible photo-oxidation reaction is rapid (30 s  is usually 
adequate) and can be performed in situ on slide-mounted cells 
or  sections  of tissue  directly under  the  microscope.  Photo- 
oxidation occurs with either unfiltered UV light (from a mer- 
cury or xenon source) or with the band pass filtered excitation 
light between 340-380 nm of the Leitz #513410  filter combi- 
nation. Using epifluorescent illumination the emission is quite 
bright and does not require image intensification. In agreement 
with O'Kane et al. (47) excitation maxima at 307  nm (minor) 
and 336 nm (major) and emission maxima at 416 nm (minor) 
and 506 nm (major) were measured for the yellow TFP photo- 
oxidation product that migrates with an Rf of 0.04 in 50:50:1.5 
methanol:acetone:triethanolamine on silica gel G  (Rf of TFP 
is 0.48).  These parameters were used to choose the above Leitz 
filter combination. The Zeiss BG3  excitation and  50  barrier 
filter combination is also acceptable but  allows more  cross- 
channel leak when used with fluorescein. Bleaching does not 
occur with TFP* and, in fact, samples usually increase some- 
what  in  brightness  during  observation.  The  excitation  and 
emission spectra of TFP*  allow double or triple fluorescent 
staining  with  rhodamine-  or  fluorescein-labeled antibodies. 
The  distribution of TFP*  fluorescence was  found to be  the 
same in cells that were unfixed, formaldehyde-fixed, acetone- 
fixed, or both, and to be stable for more than a month in slides 
stored at 4°C under 50% glycerol. Cells not subjected to acetone 
extraction were the brightest. 
In  lymphocytes  that  have  been  unchallenged  by  anti-Ig 
antibodies,  photo-oxidized  trifluoperazine  fluorescence  is 
found throughout the cell, often concentrated in one or more 
diffuse areas (Fig. 4). Occasionally, a radiating star-sapphire- 
like distribution is observed that is reminiscent of the tubulin 
distribution seen in lymphocytes (29, 71). In patched lympho- 
cytes, Ig patches and large patches of TFP* are both observed, 
but the two fluorescent species distribute independently of one 
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intestine were labeled heavily in the microvilli and throughout 
the cytoplasm except for the nucleus and the terminal web (not 
shown).  TFP*  stains the tips of secreted trichocysts in  Para- 
mecium (39).  All of these structures  have  been  shown  to  be 
occupied  by CaM  using immunofluorescence  and  immunoe- 
lectron microscopy techniques (13, 25, 43, 63, 70). 
Antibody staining 
Staining of lymphocytes with rabbit anti-brain calmodulin 
antibodies (RACaM) revealed staining patterns similar to those 
FIGURI:  4  Localization of  calmodulin  in  lymphocytes using  a flu- 
orescent  trifluoperazine  derivative.  Trifluoperazine  (TFP)  can  be 
photo-oxidized to a highly fluorescent derivative (TFP*)  which binds 
to calmodulin.  In  lymphocytes which  have been unchallenged  by 
anti-immunoglobulin antibodies (A) photo-oxidized trifluoperazine 
fluorescence  is  found  throughout  the  cell,  often  concentrated  in 
one or more diffuse areas. Occasionally, a radiating star-sapphirelike 
distribution  is observed, which  is reminiscent of the tubulin distri- 
bution  seen  in  lymphocytes. In  patched  lymphocytes (B),  surface 
antibody patches and large patches of TFP*  are both observed, but 
the two fluorescent species distribute independently of one another 
and  do  not  necessarily  map  one-on-one.  In  capped  lymphocytes 
(C), TFP*  is concentrated under the cap or throughout the uropod 
of the cell. Non-uniform TFP* fluorescence is also observed in anti- 
immunoglobulin  negative cells  (presumably T  lymphocytes).  In  B 
and  C  the top  row  is fluorescein-labeled goat anti-mouse  Ig and 
the  bottom  row  is  TFP*.  In  C  the  right  hand  group  of  cells  was 
stained  after formaldehyde fixation  and  cold  acetone permeabili- 
zation,  whereas other  samples  received  no  acetone treatment.  X 
450. 
another  and  do  not  necessarily  map  one-on-one.  In  capped 
lymphocytes, TFP* is concentrated under the cap or through- 
out the uropods of motile cells; the frequency of co-localization 
with  anti  Ig is 82%  (N  =  56  cells). This  is the  same region 
stained in capped lymphocytes by anti-actin, anti-myosin, anti- 
tubulin, and alpha-actinin antibodies, suggesting an association 
of TFP*  with  the  cytoskeleton. Non-uniform  TFP*  fluores- 
cence is also observed in anti-Is negative cells (presumably T 
lymphocyte). That TFP seems to be associated with the cyto- 
skeleton and  other  known  sites of CaM  localization is sup- 
ported by staining of aortic smooth muscle cells from calf and 
rat where TFP* brightly stains stress fibers (see Fig. 7). Diffuse 
staining is seen in a  perinuclear halo usually concentrated on 
one  end  of  the  nucleus.  The  intensity  there  and  in  other 
diffusely  stained  sites  matches  that  of  anti-smooth  muscle 
myosin  antibodies  in  the  same  cells.  The  pattern  of TFP* 
fluorescence is the same whether or not the cells are acetone 
permeabilized  following fixation.  Similar staining  occurs  in 
3T3,  PtK,  and  aortic  endothelial cells  although  stress  fiber 
staining is not as intense as in smooth muscle. At high concen- 
trations TFP* stains nucleoli where myosin light chain kinase 
has  recently  been  demonstrated  (24).  Glycerinated chicken 
skeletal muscle myofibrils are stained in  the  A  bands where 
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FLGURE  5  Staining of Iymphocytes with anticalmodulin antibodies. 
Staining  of  lymphocytes  with  anti-calmodulin  antibodies  shows 
diffuse  and  somewhat  patchy distribution  in  cells  that  are either 
untreated or are covered with anti-lg patches. Anti-CaM "patches" 
are  more  frequent  in  Ig-patched  cells,  but  do  not  necessarily  lie 
directly under each Ig patch. In capped cells, however, calmodulin 
is preferentially located under caps and in uropods. This staining is 
specific for CaM as fluorescence is inhibited by incubating cells and 
antibody in the presence of soluble CaM and no staining is observed 
with  secondary antibody alone. Identical  staining  patterns are ob- 
served with rabbit anti-calf brain CaM and sheep anti-rat testis CaM 
(CAABCO).  (A-F) Three groups of capped cells showing co-locali- 
zation  of  anti-lg  and  anti-calf  brain  CaM,  (C-F)  are  specificity 
controls. (A, C, and E) FITC-goat anti-mouse Ig. (B) RITC-goat anti- 
rabbit  Ig  plus  rabbit  anti-calf  brain  CaM  in  I%  BSA  plus  I%  goat 
serum. (D) As in B, but in the presence of 100#g/ml CaM. (F) RITC- 
goat anti-rabbit Ig only (G-l) Patched and capped cells stained with 
FITC-rabbit anti-mouse Ig (G  and  I)  and RITC-rabbit anti-sheep Ig 
plus sheep anti-rat testis CaM (CAABCO)  (H and I ) in the presence 
of 1% BSA plus 1% rabbit serum, x  700. Smooth  muscle  cells stained  with  anti-CaM  were  labeled 
brightly along stress fibers. Diffuse staining was found through- 
out the ceils, but was concentrated in the perinuclear region. 
Little or no  staining was observed in  the  nuclei and,  unlike 
staining with TFP*, nucleoli were unlabeled, perhaps because 
of incomplete penetration (Fig. 7). 
FIGURE  6  Correlation of  TFP*  and  anti-CaM staining.  In  capped 
lymphocytes stained with both anti-CaM antibodies and TFP* there 
was excellent correspondence in staining pattern between fluores- 
cein-tagged anti-lg caps, and submembranous rhodamine-labeled 
anti-CaM  and  TFP* fluorescence.  The  figure  shows  four  sets of 
capped  cells  (A-D)  stained  with  fluorescein-labeled goat  anti- 
mouse Ig  (column  F),  rhodamine-labeled goat anti-rabbit Ig plus 
rabbit anti-calf brain calmodulin (column  R), and photo-oxidized 
trifluoperazine (column  T). x  450. 
described for TFP* (Figs. 5 and 6). Unchallenged lymphocytes 
were diffusely stained, but a  fine reticular pattern was often 
superimposed on  a  diffuse  background  and  nuclei were  not 
brightly stained. Patched lymphocytes were similar to unchal- 
lenged cells and we could not determine whether there was co- 
localization of anti-CaM with anti-Ig at this stage of receptor 
redistribution. Capped cells were preferentially stained in uro- 
pods and  under  caps with  anti-CaM; 61%  (N  -  66)  of ceils 
with  Ig  caps  had  submembranous  anti-CaM  fluorescence. 
When soluble CaM was included with the primary antibody, 
staining was significantly reduced and the secondary antibody 
alone (RITC-GARIg) gave little or no staining. These obser- 
vations demonstrate the specificity of the affinity-purified an- 
tiserum. In capped cells stained with all three reagents (anti-Ig, 
anti-CaM, and TFP*, Fig. 6) there was excellent correspond- 
ence of staining pattern; 73% (N -- 30) of cells with TFP* and 
Ig "caps" were also positive for anti-CaM antibody "caps". As 
with TFP*, lg negative cells (T lymphocytes) were occasionally 
asymmetrically stained with anti-CaM (14%, N =  50). Identical 
staining patterns were obtained with sheep anti-rat testis cal- 
modulin  (CAABCO)  and  35  out  of  50  cells  with  Ig  caps 
contained  submembranous  calmodulin  "caps"  (Fig.  5).  The 
observation that  61-70%  (not  100%) of cells with surface  Ig 
caps also displayed submembranous CaM accumulations sug- 
gests that a transient association of CaM with cap components 
occurs. CaM  may be recruited from a  total intracellular pool 
to different sites of action in the lymphocyte much as it moves 
between I and A bands in skeletal muscles in different states of 
contraction (25) or as it moves from the cytosol to the plasma 
membrane of rat pituitary cells after the binding of gonadotro- 
pin releasing hormone which,  like Ig, is patched and capped 
(12). 
DISCUSSION 
Identification of Calmodulin  in Lymphocytes 
A protein exhibiting the characteristic properties of calmod- 
ulin has been isolated from splenic lymphocytes. Lymphocyte 
CaM demonstrates calcium-dependent binding to phenothia- 
zincs  and  this  feature  was  used  to  purify  CaM  by  affinity 
chromatography on Fluphenazine-Sepharose, to which it binds 
in the presence of calcium and elutes with EGTA. Lymphocyte 
CaM co-migrates with calf brain CaM in SDS PAGE and its 
apparent molecular weight varies as a  function of calcium in 
the sample, reflecting the conformational change induced by 
calcium binding. The isoelectric point of lymphocyte CaM is 
the same as that measured for brain CaM (pi =  3.9) and the 
protein stimulates CaM-dependent cAMP phosphodiesterase. 
Taken  together,  these  properties  define  a  calmodulin  with 
features of CaM's isolated from other sources (9,  10,  11, 65). 
Effects of Calmodulin Inhibitors 
Pharmacological experiments indicate that inhibitors of cal- 
modulin  are  inhibitors  of ligand-induced capping  (but  not 
patching)  of surface  immunoglobulin on  murine  B  lympho- 
cytes. Preformed Ig caps are also dispersed by these inhibitors. 
Therefore the maintainance of caps as well as their formation 
requires the action of calmodulin. Not only do CaM inhibitors 
block capping, but they do so with dose responses that closely 
match their in vitro antagonism of CaM-dependent enzymes 
such as cAMP phosphodiesterase, myosin light chain kinase, 
and Ca  ++ transport ATPase (22, 27, 60, 64, 66, 67). Especially 
important are the observations that: (a) the inhibitor analogues 
W5  and phenothiazine sulfoxides, which are inactive or only 
slightly active against CaM,  are  also ineffective in  blocking 
capping,  and  (b)  that  CaM  inhibitors with  widely differing 
chemical structures can block capping. These results argue that 
the anti-capping effects are tied to the anti-CaM effects and 
are not due to general toxicity or membrane-perturbing prop- 
erties (49). Furthermore, no significant alterations in membrane 
structure were detected with membrane probes DPH and Hedaf 
(69)  in  the  presence  of phenothiazines,  nor  was  the  lateral 
diffusion of Fab'-labeled surface Ig significantly altered (69). 
Because the drugs are reversible and wash out, their action is 
not likely to be simply a toxicity artifact. The pharmacological 
data  presented  here  are  in  good  agreement  with  previous 
studies from this laboratory and others that have examined the 
effects of phenothiazines and local anesthetics on capping of B 
lymphocytes as well as B and T lymphoma cells (2, 42, 48, 51). 
In earlier reports, the anti-calmodulin action of the drugs was 
not recognized. In light of what is now known,  however, we 
may  add  the  following compounds  to  the  list  of surface  Ig 
capping inhibitors which are also known calmodulin inhibitors: 
dibucaine, tetracaine, lidocaine =  xylocaine, procaine, phena- 
caine, and vinblastine; many of their structural analogues are 
also anti-capping agents (42, 48, 51; our unpublished observa- 
tions). Calrnodutin inhibitors also block capping of Fc receptors 
and  TL  antigen  on  B  lymphocytes,  but  not  H2  or  Thy  1 
antigens on  T  cells (6).  In  the  T  lymphoma  line BW  5147, 
NttSON  tt At.  Capping  of Surface Immunoglobulin  777 FIGURE  7  Localization of calmodulin  in cultured  cells and  myofibrils.  Rat aortic smooth  muscle ceils  were stained  by indirect 
immunofluorescence with anti-CaM antibodies (A and B) and with photo-oxidized trifluoperazine (C). With  the antibody, diffuse 
staining is found throughout the cells and is concentrated in the perinuclear region. Stress fibers are also labeled, but little staining 
is observed in nuclei. TFP* also stains perinuclear regions of cells and along stress fibers. When used at high concentrations, nuclei 
are diffusely  fluorescence and  nucleoli are brightly stained. Similar staining occurs  in 3]3,  PtK,  and aortic endothelial cells  (not 
shown).  Glycerinated chicken  skeletal  muscle  fibrils  are stained  in  the  "A"  bands  by TFP*.  (A  and  B)  Nomarski  differential- 
interference contrast/immunofluorescence  pairs of rat smooth  muscle cells stained with  anti-CaM antibodies.  (C)  Fluorescence 
photos of  calf  (left,  formaldehyde-fixed and  acetone permeabilized)  and  rat  (right,  formaldehyde-fixed)  aortic smooth  muscle 
stained with photo-oxidized trifluoperazine. Inset:  glycerinated chicken myofibril in phase contrast and stained with TFP*.  x  750. 
Bourguignon (2) found that the antigens T200, gp69/71, and 
Thy-1 are inhibited by trifluoperazine and speculated that this 
was related to the drug's anti-CaM activity. In WiLL a human 
lymphoma  cell  line,  Con  A  capping  was  not  inhibited  by 
trifluoperazine  but  the  distribution  of calmodulin  itself was 
altered (52). 
Intracellular Localization of Calmodulin 
Localization of calmodulin in lymphocytes in various stages 
of surface Ig redistribution suggests that this protein associates 
with the cytoskeleton. Staining with three independent  CaM- 
labeling  reagents  demonstrated  nearly  identical  calmodulin 
distributions.  In untreated lymphocytes, rabbit anti-calf brain 
CaM,  sheep  anti-rat  testis  CaM  (CAABCO)  and  photo-oxi- 
dized trifluoperazine all show diffuse fluorescence throughout 
the cytoplasm with common local accumulations. In Ig patched 
cells,  CaM  distribution  is  also  more patchy but  intracellular 
CaM  "patches"  do  not  necessarily  lie  directly beneath  each 
surface Ig patch. In capped cells there is a dramatic change in 
the CaM distribution and intense fluorescence is found under 
caps and in uropods. This is remarkably similar to the behav- 
iors  observed  for actin,  myosin,  tubulin,  and  alpha-actinin, 
which,  although  their  initial  distributions  vary,  all  become 
concentrated  under caps and  often are  found underneath  Ig 
patches  (3,  5,  20,  71).  This  co-localization  suggests  that  the 
action  of CaM  in capping is  via the  contractile  or gelation- 
solation activities of the cytoskeleton which is especially im- 
portant in the later stage of Ig redistribution.  Salisbury et al. 
(52)  have also demonstrated the concentration of CaM under 
Con A caps in the WiL2 human lymphoma cell line.  The same 
correlation between CaM and cytoskeleton has been described 
by  others  for  a  variety  of tissues  and  cultured  cells  using 
antibody-labeling techniques and this is true for our antiserum 
as well. 
The specificity of the anti-calf brain calmodulin antibody is 
indicated  by (a) the electrophoretic purity of the antigen,  (b) 
the affinity purification of the antibody on immobilized pure 
antigen,  (c)  the  observation  that  staining  intensity  is  signif- 
icantly reduced  in  the presence  of soluble  CaM,  but  not  1% 
bovine serum albumin or  1% goat serum, (d) lack of staining 
by secondary antibody alone, (e) similarity of staining pattern 
to  that  of sheep  anti-rat  testis  CaM  (CAABCO),  and  (f) 
correspondence of staining patterns observed with other anti- 
CaM  antibodies  in  lymphoma  and  other  cultured  cells  and 
Paramecium. 
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verified by its co-localization with anti-CaM antibodies and its 
biochemical binding properties. Known intracellular concen- 
trations of calmodulin which are labeled by TFP*  are: under 
lymphocyte caps, along stress fibers, in the microviUi and cell 
body, but not  in  the  terminal web  of isolated brush  border 
cells, on skeletal muscle A  bands,  on  secreted trichocysts of 
Paramecium  (39)  and  staining  of nucleoli that  contain  the 
CaM-dependent myosin light chain kinase (13, 24, 25, 63, 70). 
In  the  case  of skeletal muscle,  calmodulin  is  known  to  be 
located on either the I  or A  band depending on the state of 
contraction (25). Here, it is significant that TFP* preferentially 
stains one discrete region as the contractile state of the fiber 
was not controlled. 
The actual mode of in situ  labeling is not precisely known, 
but  there  are  two  likely mechanisms.  First,  in  situ  labeling 
would generate the highly fluorescent photo-oxidation product 
described by O'Kane et al. (47),  which would bind to CaM in 
a  calcium-dependent fashion.  Formaldehyde fixation and/or 
acetone  extraction  may  leave calcium-loaded CaM  in  place 
and active following rehydration so that it could bind TFP* in 
this way. Alternatively, a highly reactive photo-oxidation prod- 
uct such as described by Prozialeck et al. (50, 66) may cova- 
lently label via a  free radical addition to CaM  to which the 
unactivated precursor, trifluoperazine, was bound. The TFP* 
might  also be subject to  nucleophilic attack by the  CaM  to 
which  TFP  was  bound  at  the  time  of illumination.  When 
EGTA-containing buffer was used to rehydrate or wash follow- 
ing fixation and/or acetone extraction, no obvious decrease in 
TFP* labeling occurred. Similarly, illumination in the presence 
of nonfluorescent phenothiazines was not effective in compet- 
ing  TFP*  from  its  binding  sites  and  multiple  washes  and 
extensive storage over 50% glycerol failed to significantly re- 
duce staining. This favors a covalent mechanism of labeling. 
Summary 
From the evidence presented above and from what is known 
about the actions of calmodulin in other systems, we propose 
that calmodulin is required for the energy-dependent capping 
of surface immunoglobulin. Calmodulin may be a component 
of patches as well but is not required for their formation. 
Two general mechanisms can be envisaged to explain cal- 
modulin's activity and one or both may be operating. Either 
CaM  regulates the contractile or gelation/solation activity of 
the actomyosin-based cytoskeleton, or it regulates the attach- 
ment of the cytoskeleton to membrane-bound immunoglobulin 
and its complexes with other membrane proteins. In favor of 
the  first  mechanism  are  the  observations that  (a)  CaM  co- 
localizes with the cytoskeleton in lymphocytes (5, 20, 2 l, 71) as 
well as with actomyosin-rich structures in other cells such as 
stress fibers (13),  microvilli (43),  skeletal muscle  "A"  bands 
(25),  and  the ends of mitotic spindles (13,  25,  64);  (b)  CaM 
regulates the action of myosin via its CaM-dependent myosin 
light chain kinase (24, 62); (c) myosin light chains are phos- 
phorylated during capping of T  lymphoma cells (2);  (d) CaM 
inhibitors cause relaxation of smooth muscle cells and  block 
the superprecipitation of their crude extracts (28);  (e) muscle 
cell energy reserves are regulated by CaM via glycogen synthe- 
tase (10,  11) and (f) CaM inhibitors prevent the spreading of 
cultured fibroblasts (60, 66). 
The second mechanism is supported by a variety of findings. 
Platelet  shape  changes  and  the  binding  of von  Willebrand 
factor VIII to platelet surface receptors are specifically altered 
by CaM inhibitors (31). The binding of gonadotropin-releasing 
hormone to pituitary cells (which is followed by patching and 
capping) causes the translocation of calmodulin from the cy- 
tosol  to  the  plasma  membrane  (12).  The  shapes  of  intact 
erythrocytes and erythrocyte ghosts are altered by calmodulin 
inhibitors, specifically they cause "cupping"  (15;  our unpub- 
lished observations). The shape of erythrocytes is controlled by 
the  peripheral membrane  protein spectrin,  which  binds cal- 
modulin and  is phosphorylated by a  CaM dependent kinase 
(30, 55). Actin is known to bind to the erythrocyte membrane 
via  a  complex  of proteins  including  spectrin,  ankyrin,  and 
bands  3  and  4.1  (4).  Recently,  it  has  become  evident  that 
proteins chemically and  immunologically related to spectrin 
and ankyrin have been found in other cell types, which suggests 
that  actin  may  attach  to  their  membranes  by  mechanisms 
analogous to that in the erythrocyte (1,  32,  38).  One of these, 
fodrin,  redistributes  under  the  membrane  of  lymphocytes 
capped with anti-H2 and anti-Ig antibodies (38).  Furthermore, 
microfilaments have been observed to be displaced from the 
membranes of cultured cells by CaM-inhibiting drugs which 
are also capping inhibitors (48). 
Therefore, the action of calmodulin in the capping of lym- 
phocyte surface immunoglobulin may be a specific instance of 
a  general  calmodulin  activity in  regulating  cell  membrane 
topography and cell shape. These functions would be regulated 
by the action of calmodulin on the cytoskeleton and the latter's 
sites of interaction with the cell membrane. 
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